When combining ctDNA and conventional serum tumor markers such as carcinoembryonic antigen (CEA), CA (carbohydrate antigen) 19‐9, and CA 72‐4, a significantly higher efficacy than ctDNA or any tumor markers alone was observed. This evidence concerns the gene CEACAM5 and neoplasm.